182 related articles for article (PubMed ID: 2370110)
1. Immunization against chlamydial genital infection in guinea pigs with UV-inactivated and viable chlamydiae administered by different routes.
Rank RG; Batteiger BE; Soderberg LS
Infect Immun; 1990 Aug; 58(8):2599-605. PubMed ID: 2370110
[TBL] [Abstract][Full Text] [Related]
2. Characterization of chlamydial genital infection resulting from sexual transmission from male to female guinea pigs and determination of infectious dose.
Rank RG; Bowlin AK; Reed RL; Darville T
Infect Immun; 2003 Nov; 71(11):6148-54. PubMed ID: 14573630
[TBL] [Abstract][Full Text] [Related]
3. Immunity to reinfection and immunization of male guinea pigs against urethral infection with the agent of guinea pig inclusion conjunctivitis.
Patterson TL; Rank RG
Sex Transm Dis; 1996; 23(2):145-50. PubMed ID: 8919742
[TBL] [Abstract][Full Text] [Related]
4. Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis.
Batteiger BE; Rank RG; Bavoil PM; Soderberg LS
J Gen Microbiol; 1993 Dec; 139(12):2965-72. PubMed ID: 7510322
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the humoral immune response to chlamydial genital infection in guinea pigs.
Batteiger BE; Rank RG
Infect Immun; 1987 Aug; 55(8):1767-73. PubMed ID: 3610314
[TBL] [Abstract][Full Text] [Related]
6. Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.
Lu C; Zeng H; Li Z; Lei L; Yeh IT; Wu Y; Zhong G
Vaccine; 2012 Jan; 30(2):475-85. PubMed ID: 22079265
[TBL] [Abstract][Full Text] [Related]
7. Protective role of serum antibody in immunity to chlamydial genital infection.
Rank RG; Batteiger BE
Infect Immun; 1989 Jan; 57(1):299-301. PubMed ID: 2909492
[TBL] [Abstract][Full Text] [Related]
8. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
Pal S; Luke CJ; Barbour AG; Peterson EM; de la Maza LM
Vaccine; 2003 Mar; 21(13-14):1455-65. PubMed ID: 12615442
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to reinfection after a primary chlamydial genital infection.
Rank RG; Batteiger BE; Soderberg LS
Infect Immun; 1988 Sep; 56(9):2243-9. PubMed ID: 2457553
[TBL] [Abstract][Full Text] [Related]
10. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
[TBL] [Abstract][Full Text] [Related]
11. Use of enteric vaccines in protection against chlamydial infections of the genital tract and the eye of guinea pigs.
Nichols RL; Murray ES; Nisson PE
J Infect Dis; 1978 Dec; 138(6):742-6. PubMed ID: 739153
[TBL] [Abstract][Full Text] [Related]
12. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.
Igietseme JU; Uriri IM; Kumar SN; Ananaba GA; Ojior OO; Momodu IA; Candal DH; Black CM
Infect Immun; 1998 Sep; 66(9):4030-5. PubMed ID: 9712743
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.
Su H; Messer R; Whitmire W; Fischer E; Portis JC; Caldwell HD
J Exp Med; 1998 Sep; 188(5):809-18. PubMed ID: 9730883
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract.
Igietseme JU; Rank RG
Infect Immun; 1991 Apr; 59(4):1346-51. PubMed ID: 1900810
[TBL] [Abstract][Full Text] [Related]
15. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.
Igietseme JU; Murdin A
Infect Immun; 2000 Dec; 68(12):6798-806. PubMed ID: 11083798
[TBL] [Abstract][Full Text] [Related]
16. Target tissues associated with genital infection of female guinea pigs by the chlamydial agent of guinea pig inclusion conjunctivitis.
Barron AL; White HJ; Rank RG; Soloff BL
J Infect Dis; 1979 Jan; 139(1):60-8. PubMed ID: 374637
[TBL] [Abstract][Full Text] [Related]
17. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
[TBL] [Abstract][Full Text] [Related]
18. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
[TBL] [Abstract][Full Text] [Related]
19. Use of a Guinea pig-specific transcriptome array for evaluation of protective immunity against genital chlamydial infection following intranasal vaccination in Guinea pigs.
Wali S; Gupta R; Veselenak RL; Li Y; Yu JJ; Murthy AK; Cap AP; Guentzel MN; Chambers JP; Zhong G; Rank RG; Pyles RB; Arulanandam BP
PLoS One; 2014; 9(12):e114261. PubMed ID: 25502875
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization with a novel lipid-based adjuvant protects against genital Chlamydia infection.
Hickey DK; Aldwell FE; Beagley KW
Vaccine; 2010 Feb; 28(7):1668-72. PubMed ID: 20026449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
